3 posts
Standard
Federal regulators have granted clearance to a new diagnostic aid designed to assist clinicians in the complex process of identifying autism in children. The tool, known as Neurora, was developed by Argus Cognitive, Inc. and received formal authorization from the Food and Drug Administration this month. It is intended to serve as a supportive resource…
Standard
Federal regulators have cleared a novel artificial intelligence and biometric tool designed to assist clinicians in identifying children with autism, marking another step forward in the technological landscape of developmental disability screening. The Food and Drug Administration cleared the diagnostic support tool, known as Neurora, to inform clinical decisions regarding children between the ages of…
Standard
Federal regulators have granted clearance to a new diagnostic tool designed to assist healthcare professionals in identifying autism spectrum disorder in children, marking another step forward in the integration of biometric technology into pediatric care. The Food and Drug Administration cleared the tool, known as Neurora, to inform clinical decisions regarding children ranging from 18…
